Found: 25
Select item for more details and to access through your institution.
Optimal infused CD34<sup>+</sup> cell dose in multiple myeloma patients undergoing upfront autologous hematopoietic stem cell transplantation.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01165-w
- By:
- Publication type:
- Article
Cytomegaloviral Infections in Recipients of Chimeric Antigen Receptor T-Cell Therapy: An Observational Study With Focus on Oncologic Outcomes.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 8, p. 1, doi. 10.1093/ofid/ofae422
- By:
- Publication type:
- Article
Immune effector cell-associated enterocolitis following chimeric antigen receptor T-cell therapy in multiple myeloma.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01167-8
- By:
- Publication type:
- Article
Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01062-2
- By:
- Publication type:
- Article
Multiple myeloma patients with a long remission after autologous hematopoietic stem cell transplantation.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-024-01062-2
- By:
- Publication type:
- Article
Outcomes of patients with multiple myeloma and 1q gain/amplification receiving autologous hematopoietic stem cell transplant: the MD Anderson cancer center experience.
- Published in:
- Blood Cancer Journal, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41408-023-00973-w
- By:
- Publication type:
- Article
Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantation.
- Published in:
- British Journal of Haematology, 2024, v. 204, n. 5, p. 1944, doi. 10.1111/bjh.19384
- By:
- Publication type:
- Article
Outcomes of young adults (aged ≤ 40 years) with newly diagnosed multiple myeloma after up‐front autologous stem cell transplant.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 4, p. 866, doi. 10.1111/bjh.18944
- By:
- Publication type:
- Article
Impact of gender on outcomes of patients with multiple myeloma undergoing autologous Haematopoietic stem cell transplant.
- Published in:
- British Journal of Haematology, 2023, v. 201, n. 4, p. e37, doi. 10.1111/bjh.18753
- By:
- Publication type:
- Article
Outcomes of lenalidomide retreatment with novel triplet regimens in patients with multiple myeloma progressing on lenalidomide‐based maintenance therapy.
- Published in:
- British Journal of Haematology, 2021, v. 193, n. 3, p. e23, doi. 10.1111/bjh.17393
- By:
- Publication type:
- Article
Single‐agent lenalidomide maintenance after upfront autologous stem cell transplant for newly diagnosed multiple myeloma: The MD Anderson experience.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1571, doi. 10.1002/ajh.27029
- By:
- Publication type:
- Article
Outcomes of patients with limited‐stage plasmablastic lymphoma: A multi‐institutional retrospective study.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 2, p. 300, doi. 10.1002/ajh.26784
- By:
- Publication type:
- Article
Black multiple myeloma patients undergoing upfront autologous stem cell transplant have similar survival outcomes compared to Whites: A propensity‐score matched analysis.
- Published in:
- American Journal of Hematology, 2021, v. 96, n. 12, p. E455, doi. 10.1002/ajh.26360
- By:
- Publication type:
- Article
Outcomes of autologous stem cell transplantation in Waldenström's macroglobulinemia.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Practical Aspects of Immunotherapy: A Report from the 20th International Myeloma Society (IMS) Annual Meeting.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 6, p. 350, doi. 10.1016/j.clml.2024.03.005
- By:
- Publication type:
- Article
Retrospective Review of the Use of High-Dose Cyclophosphamide, Bortezomib, Doxorubicin, and Dexamethasone for the Treatment of Multiple Myeloma and Plasma Cell Leukemia.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Postoperative Radiotherapy for Multiple Myeloma of Long Bones: Should the Entire Rod Be Treated?
- Published in:
- 2019
- By:
- Publication type:
- journal article
Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00842-6
- By:
- Publication type:
- Article
Impact of clonal plasma cells in autografts on outcomes in high-risk multiple myeloma patients.
- Published in:
- Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00842-6
- By:
- Publication type:
- Article
A phase 1 study of filanesib, carfilzomib, and dexamethasone in patients with relapsed and/or refractory multiple myeloma.
- Published in:
- 2019
- By:
- Publication type:
- Letter
Long‐term durable efficacy of autologous stem cell transplantation in POEMS syndrome.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 3, p. E72, doi. 10.1002/ajh.25375
- By:
- Publication type:
- Article
Melphalan‐based autologous transplant in octogenarian multiple myeloma patients.
- Published in:
- American Journal of Hematology, 2019, v. 94, n. 1, p. E2, doi. 10.1002/ajh.25310
- By:
- Publication type:
- Article
Adjunct Therapy with T Regulatory Cells Decreases Inflammation and Preserves the Anti-Tumor Activity of CAR T Cells.
- Published in:
- Cells (2073-4409), 2023, v. 12, n. 14, p. 1880, doi. 10.3390/cells12141880
- By:
- Publication type:
- Article
Clinician and administrator perspectives on outpatient administration of ciltacabtagene autoleucel in relapsed or refractory multiple myeloma.
- Published in:
- Frontiers in Immunology, 2024, p. 1, doi. 10.3389/fimmu.2024.1405452
- By:
- Publication type:
- Article
Impact of pretransplant minimal residual disease in patients with multiple myeloma and a very good partial response or better receiving autologous hematopoietic stem cell transplantation.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 9, p. 1663, doi. 10.1002/cncr.35171
- By:
- Publication type:
- Article